
NorthStar leads £1.6m round in Reinnervate
NorthStar Equity Investors has led an investment round of over £1.6m in biotech start-up Reinnervate Limited.
Of the total, £500,000 came from NorthStar and the rest from private investors.
Reinnervate is a spin-out biotechnology company originating in research conducted at Durham University. It develops ways to manage the growth and function of cultured cells. Reinnervate's technologies have multiple applications and are particularly relevant to the control of stem cell differentiation and engineering tissues in in-vitro cell culture.
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote
Permira to take Ergomed private for GBP 703m
Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO
Partners Group to release IMs for Civica sale in mid-September
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Change of mind: Sponsors take to de-listing their own assets
EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater